Does Wegovy Work — and What Is Actually Happening in Your Body?

Semaglutide, the active substance in Wegovy, is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone the gut releases naturally after eating. By activating GLP-1 receptors in the brain and digestive system, semaglutide sends signals that increase the sense of fullness, reduce appetite, and slow the rate at which the stomach empties — an effect that commonly lessens over time as the body adjusts.

This combination means many people find they feel satisfied with smaller amounts of food and think about eating less frequently than before. It is worth noting that these are commonly reported effects, not a guaranteed experience — individual responses differ, and the medicine works alongside, not instead of, changes to eating habits and activity.

What the evidence generally shows

Clinical research on semaglutide has been reviewed by regulatory bodies worldwide. According to NHS guidance on semaglutide, it is prescribed as part of a wider weight-management programme including dietary guidance and physical activity — it is not a standalone solution. How much weight someone loses, and over what timeframe, varies considerably depending on starting point, lifestyle factors, dose, and individual biology.

How it differs from some other GLP-1 medicines

If you are curious about how semaglutide compares mechanistically to tirzepatide (the active substance in Mounjaro, which acts on both GLP-1 and GIP receptors), the page on how Mounjaro works covers that in more detail. Both are once-weekly injectables, but their receptor targets differ — a distinction worth understanding as background, though any question about which is right for you belongs with your prescriber.

For a broader look at the GLP-1 mechanism family, the hub on how GLP-1 medicines work brings together the key concepts in one place.

Understanding the mechanism is useful context — but the more immediate question for most people is: is it working for me, right now? Progress on a GLP-1 medicine like Wegovy is rarely linear, and the scale alone rarely tells the full story.

The most relevant GLP Trackr feature here is the daily check-in and insights dashboard. Each morning you can log weight, energy, mood, food-noise level, sleep, and water intake in around 30 seconds. Over weeks, the app's correlation explorer and weight-intelligence tools surface patterns in your own data — for example, whether your food-noise scores track with your dose timing, or how sleep quality relates to your weekly results. That kind of personalised picture is hard to see without consistent logging.

Alongside that, the weight and body tracking charts let you watch your trend over time rather than reacting to day-to-day fluctuations, and the doctor report feature lets you bring a clear summary of your journey to your next prescriber appointment — useful if you want to have an informed conversation about how your treatment is going.

If you are in the earlier stages of your Wegovy journey and wondering about timelines, the page on how long GLP-1 medicines take to work offers helpful context (written with reference to the tirzepatide data but covering general GLP-1 principles), and how fast results typically appear covers the early-weeks picture in more detail.

GLP Trackr is an information and tracking tool — it does not replace the clinical oversight of your prescriber or doctor. If you have concerns about how your treatment is progressing, whether side effects are acceptable, or whether your dose is right for you, those are conversations to have with your healthcare professional directly.

Want to start building a clear picture of your own progress? Download GLP Trackr on the App Store or Google Play and try it free for seven days — your data, your patterns, your journey in one place.